The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $19.42

Today's change+0.20 +1.04%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $19.42

Today's change+0.20 +1.04%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.

Meridian Bioscience Inc crosses above 200-day moving average

Meridian Bioscience Inc closed up Friday by (U.S.)$0.20 or 1.04% to (U.S.)$19.42 and crossing above its 200-day moving average. Over the last five days, shares have gained 3.19%, but are down 5.36% for the last year to date. Shares have outperformed the S&P 500 by 7.62% during the last year.

Key company metrics

  • Open(U.S.) $19.22
  • Previous close(U.S.) $19.22
  • High(U.S.) $19.47
  • Low(U.S.) $19.14
  • Bid / Ask(U.S.) $16.50 / (U.S.) $20.12
  • YTD % change-5.36%
  • Volume151,807
  • Average volume (10-day)191,802
  • Average volume (1-month)223,555
  • Average volume (3-month)244,385
  • 52-week range(U.S.) $16.60 to (U.S.) $21.49
  • Beta1.18
  • Trailing P/E23.06×
  • P/E 1 year forward21.98×
  • Forward PEG1.37×
  • Indicated annual dividend(U.S.) $0.80
  • Dividend yield4.12%
  • Trailing EPS(U.S.) $0.84
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.40%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue51474748
Total other revenue--------
Total revenue51474748
Gross profit34323030
Total cost of revenue18161718
Total operating expense36343434
Selling / general / administrative15151413
Research & development3333
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income15141314
Interest income (expense), net non-operating0------
Gain (loss) on sale of assets--------
Other--------
Income before tax15141314
Income after tax9989
Income tax, total6555
Net income9989
Total adjustments to net income--------
Net income before extra. items9989
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9989
Inc. avail. to common incl. extra. items9989
Diluted net income9989
Dilution adjustment0------
Diluted weighted average shares42424242
Diluted EPS excluding extraordinary itemsvalue per share0.210.210.200.22
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.210.210.200.22
R